Free Trial
NASDAQ:ISPC

iSpecimen Q4 2024 Earnings Report

iSpecimen logo
$1.26 -0.02 (-1.17%)
Closing price 05/2/2025 03:58 PM Eastern
Extended Trading
$1.20 -0.06 (-5.14%)
As of 05/2/2025 06:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

iSpecimen EPS Results

Actual EPS
-$6.28
Consensus EPS
-$4.00
Beat/Miss
Missed by -$2.28
One Year Ago EPS
N/A

iSpecimen Revenue Results

Actual Revenue
$1.48 million
Expected Revenue
$2.98 million
Beat/Miss
Missed by -$1.50 million
YoY Revenue Growth
N/A

iSpecimen Announcement Details

Quarter
Q4 2024
Time
Before Market Opens
Conference Call Date
Monday, April 14, 2025
Conference Call Time
9:30AM ET

Upcoming Earnings

iSpecimen's Q1 2025 earnings is scheduled for Tuesday, May 6, 2025, with a conference call scheduled at 8:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Earnings Documents

iSpecimen Earnings Headlines

Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week, President Trump promised to buy a Tesla to help support Musk in the face of a boycott against his company. But according to one research group, with connections to the Pentagon and the U.S. government, Elon's preparing to strike back in a much bigger way in the days ahead.
iSpecimen Shares Rise After Securring Virus Suppliers
See More iSpecimen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like iSpecimen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on iSpecimen and other key companies, straight to your email.

About iSpecimen

iSpecimen (NASDAQ:ISPC) provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables scientists to search for specimens and patients across a network of hospitals, clinics, private practice groups, laboratories, blood centers, biobanks, clinical research sites, and cadaveric donation centers. The company develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Lexington, Massachusetts.

View iSpecimen Profile

More Earnings Resources from MarketBeat